Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 7.505 USD -0.6% Market Closed
Market Cap: 102m USD
Have any thoughts about
Champions Oncology Inc?
Write Note

Wall Street
Price Targets

CSBR Price Targets Summary
Champions Oncology Inc

Wall Street analysts forecast CSBR stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSBR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
19% Downside
Average
Price Target
6.12 USD
18% Downside
Highest
Price Target
6.3 USD
16% Downside
Champions Oncology Inc Competitors:
Price Targets
300404
Boji Medical Technology Co Ltd
24% Upside
BANB
Bachem Holding AG
44% Upside
SEER
Seer Inc
32% Upside
MXCT
MaxCyte Inc
129% Upside
PIQ
Proteomics International Laboratories Ltd
20% Downside
HVO
hVIVO PLC
89% Upside
SKAN
SKAN Group AG
22% Upside
IQV
IQVIA Holdings Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Champions Oncology Inc

For the last 8 years the compound annual growth rate for Champions Oncology Inc's revenue is 21%. The projected CAGR for the next 3 years is 18%.

21%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Champions Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss

Net Income
Forecast

Net Income Estimate
Champions Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSBR's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CSBR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

What is Champions Oncology Inc's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Champions Oncology Inc's revenue is 21%. The projected CAGR for the next 3 years is 18%.

Back to Top